Zestmab 100 mg Injection
$62,56
$48,80
Zestmab 100 mg injection is a targeted monoclonal antibody therapy designed to combat various immune system-related conditions, particularly certain malignancies. This innovative treatment is especially effective for patients diagnosed with non-Hodgkin's lymphoma and chronic lymphocytic leukemia, where it works by specifically binding to cancerous cells to help the immune system recognize and destroy them. While Zestmab offers significant therapeutic benefits, it is essential for patients to be aware of potential side effects, such as infusion reactions and increased risk of infections, necessitating close monitoring by healthcare providers. This medication underscores the importance of personalized medicine, as it is tailored to enhance the body's own defenses against malignancies. As with any treatment, discussing your full medical history and any current medications with your healthcare professional is crucial to ensure the safe use of Zestmab. With ongoing research and development, Zestmab continues to represent a promising advancement in the fight against specific cancers, providing hope for improved outcomes. Always consult your doctor for comprehensive guidance on the use of this medication and to understand its place within your overall treatment plan.
數量
Active Pharmaceutical Ingredient
Uses
• Zestmab 100 mg injection is utilized in the treatment of Non-Hodgkin lymphoma (NHL), a type of cancer that affects the lymphatic system. This medication helps target and reduce the proliferation of malignant lymphocytes. Patients receiving Zestmab 100 mg injection may experience improved outcomes in managing their condition. The injection is often part of a comprehensive treatment plan tailored to individual patient needs.
• In cases of rheumatoid arthritis, Zestmab 100 mg injection can play a crucial role in alleviating symptoms and improving joint function. The medication works by modulating the immune response, thereby reducing inflammation associated with the disease. Patients may find that Zestmab 100 mg injection helps them achieve better control over their arthritis symptoms. This can lead to enhanced mobility and overall quality of life.
• Zestmab 100 mg injection is also indicated for the treatment of chronic lymphocytic leukaemia (CLL), a type of blood cancer characterized by the accumulation of abnormal lymphocytes. The injection targets these cancerous cells, aiding in their reduction and promoting healthier blood cell production. By utilizing Zestmab 100 mg injection, healthcare providers can offer patients a valuable option in their cancer treatment regimen. This can lead to a more favorable prognosis for those affected by CLL.
• Additionally, Zestmab 100 mg injection is effective in treating conditions such as granulomatosis with polyangiitis and microscopic polyangiitis, both of which involve inflammation of blood vessels. The medication helps to suppress the immune system's overactivity, thereby reducing the associated inflammation and damage. Patients using Zestmab 100 mg injection may experience a decrease in symptoms related to these vasculitis disorders. This treatment can be an essential part of managing chronic inflammatory conditions.
Benefits
Non-Hodgkin lymphoma (NHL): Non-Hodgkin's lymphoma is a form of cancer that affects the white blood cells in the body. These cells are responsible for preventing infections. Zestmab 100 mg Injection has been demonstrated to reduce the immune response and relieve pain and inflammation. It also can kill cancer cells and prevent their further growth. To prevent the spread of infection, it is advisable to avoid crowds and to wash your hands frequently. It is recommended that patients consume an adequate quantity of fluids unless otherwise advised by their physician.
Rheumatoid arthritis: Zestmab 100 mg is an immunosuppressant that is used to treat rheumatoid arthritis. It is administered in a dose and frequency that is tailored to the patient's condition. This is determined by the physician. It is crucial to adhere to the physician's instructions and to promptly report any adverse effects, including fever, chills, or other symptoms, to the physician.
Blood cancer (chronic lymphocytic leukemia): Leukemia, also known as blood cancer, is a malignant neoplasm of the hematopoietic tissues that impairs the body's ability to combat infection. Zestmab 100 Injection is a chemotherapeutic agent that kills or inhibits the proliferation of malignant cells and is effective in the treatment of leukemia. However, it is important to discuss the potential side effects and benefits of this medication with a qualified healthcare professional. It is also essential to inform your doctor of any adverse effects that may arise during treatment.
Granulomatosis with polyangiitis: Granulomatosis with polyangiitis (GPA) is a condition that causes inflammation of the blood vessels of the ears, nose, throat, lungs, and kidneys. In this condition, the blood flow to these areas may be reduced, which can lead to their damage. Zestmab 100 mg Injection is an effective treatment that helps reduce inflammation, pain, and swelling and prevents further damage. This improves the quality of life of those affected by GPA.
Microscopic polyangiitis: Microscopic polyangiitis is an autoimmune disease that affects the small blood vessels and may be caused by an imbalance in the immune system. Zestmab 100 mg Injection reduces the immune response and improves inflammation. This helps to heal the condition and to alleviate discomfort.
Side Effects
Zestmab 100 mg Injection can cause various adverse effects that can differ from one person to another. Some of the adverse effects of the drug are listed below.
Most Common Side Effects
• Low Immunity
• Nausea
• Tinnitus
• Muscle Pain and Stiffness
• Face Swelling
• Low Blood Count of White Blood Cells and Red Blood Cells
• Increase in Glucose Levels in Blood
• Headache
Common Side Effects
• Skin Reactions
• Heart Problems
• Infections
• Allergies
How To Use
The administration of Zestmab 100 Injection is typically conducted by a medical professional, such as a doctor or nurse, in a medical facility, such as a hospital or clinic. It is not advisable to administer the product independently, and it is important to adhere to the instructions provided by a qualified healthcare professional.
Safety Advice
• Alcohol: Caution should be exercised when drinking alcohol with Zestmab 100 mg. Please consult your doctor.
• Kidney: Zestmab 100 mg Injection is likely to be safe in patients with kidney disease. The limited data available suggest that dose adjustment of Vortuxi Solution for Infusion may not be necessary for these patients. Please consult your doctor.
• Breastfeeding: Zestmab 100 mg Injection is likely to be safe to use while breastfeeding, and limited human statistics support that the drug now no longer poses a good risk to the baby.
• Liver: Zestmab 100 mg Injection is not recommended in patients with active liver disease or those who have had viral hepatitis. Please consult your doctor.
• Pregnancy: Zestmab 100 mg Injection may not be safe for use during pregnancy. Although there is limited human research, animal research has shown dangerous effects on the growing baby. Your doctor will weigh up the benefits and potential risks before prescribing it to you. Please consult your doctor.
• Driving: It is not known whether Zestmab 100 mg affects your ability to drive. Do not drive if you experience symptoms that affect your ability to concentrate and react.